SCIESCOPUSQ1
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
FRONTIERS MEDIA SA, Switzerland
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES is an academic journal published by FRONTIERS MEDIA SA (Switzerland). Identifiers: eISSN 1482-1826. Indexed in SCIE, SCOPUS. Metrics: JIF 4.3, CiteScore 6.5, SJR 0.720, SNIP 0.90. Subject areas: PHARMACOLOGY & PHARMACY. tlooto lists 169 papers from this journal.
CiteScore
6.50
Scopus citation metric
SJR
0.720
SCImago rank
SNIP
0.90
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- -
- eISSN
- 1482-1826
- Abbreviation
- J PHARM PHARM SCI
- Publisher
- FRONTIERS MEDIA SA
- Country
- Switzerland
Web of Science categories
SCIEPHARMACOLOGY & PHARMACY
Scopus ASJC categories
3003 Pharmaceutical Science3004 Pharmacology
Keywords
Pharmacology & Pharmacy
Papers in this journal
Recent papers
- Integrative deep learning strategies to enhance early-stage drug discovery: optimizing computational structure–activity modeling for pharmacotherapeutic innovation
2026
- Old drugs, new weapons: current trends in repurposing therapies against antimicrobial resistance
2026
- Rethinking asthma therapy, part 2: transdermal strategies for adjunct asthma and allergy treatments
2026 · 1 citations
- Drug-related problems and their predictors in pediatric community-acquired infections: the role of pharmacist-led interventions in Pakistan.
2026
- Refined pharmacovigilance assessment of immune checkpoint inhibitors-related bullous pemphigoid: a multi-methodological approach utilizing FAERS database
2026 · 2 citations
Most cited papers
- The WTO and India’s Pharmaceutical Industry (Patent Protection, TRIPS, and Developing Countries)
2009 · 182 citations
- Computational Drug Design – A Guide for Computational and Medicinal Chemists
2011 · 68 citations
- Inhibition of monosodium urate crystal-induced inflammation by withaferin A.
2009 · 49 citations
- Real-world data: a comprehensive literature review on the barriers, challenges, and opportunities associated with their inclusion in the health technology assessment process
2024 · 47 citations
- Current investigations for liver fibrosis treatment: between repurposing the FDA-approved drugs and the other emerging approaches
2023 · 37 citations